Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Fleischer, MD
Children's Hospital Colorado
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Allergy Medical
Brisbane, Australia
- Princess Margaret Hospital for Children
Perth, Australia
- Children'S Hospital Westmead
Sydney, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cheema Research Inc.
Mississauga, Ontario, Canada
- Ottawa Allergy Asthma Research Institute
Ottawa, Ontario, Canada
- Gordon Sussman Clinical Research Inc.
Toronto, Ontario, Canada
- Chum & Chu Sainte-Justine
Montreal, Quebec, Canada
- Centre de Recherche Appliquée En Allergie de Québec (craaq)
Québec, Canada
- Charité Universitätsmedizin Berlin
Berlin, Germany
- St.-Marien-Hospital
Bonn, Germany
- Universitätsklinikum Erlangen
Erlangen, Germany
- Clinical Investigations Unit
Cork, Ireland
- Our Lady'S Children'S Hospital
Dublin, Ireland
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- University of California, Rady Children'S Hospital
San Diego, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- National Jewish Health
Denver, Colorado, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Boston Childrens' Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Jaffe Food Allergy Institute
New York, New York, United States
- the University of North Carolina - Chapell Hill
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Children'S Medical Center of Dallas
Dallas, Texas, United States
- Baylor College of Medicine - Texas Children'S Hospital
Houston, Texas, United States
- Asthma, Inc.
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2015
- Primary completion
- 18 Aug 2017
- Completion
- 18 Aug 2017
- Last update posted
- 18 Jun 2025
- Registered enrollment
- 500
- Registry id
- NCT02636699
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.